GLP-1 RAs Reduce Food Noise by 46%, Emerging Evidence Shows

GLP-1 receptor agonists (GLP-1 RAs) are best known for their role in weight loss and metabolic health regulation. However, emerging evidence now reveals they may also help curb persistent food cravings and food noise to support more holistic lifestyle changes. This guide explores the latest findings, including a key US-based survey showing a 46% reduction in constant thoughts about food among GLP-1 users, and what this means for patients managing obesity.

What is Food Noise and Why Does It Matter?

Food noise is defined as 'persistent thoughts about food that are perceived by the individual as being unwanted and/or distressing and may cause harm to the individual, including social, mental, or physical problems.' This concept, increasingly recognized in obesity care, differs from typical food cravings.

Food Noise vs. Food Cravings

Although food noise can contribute to food cravings, the two are not the same. Food cravings are typically intense but occasional urges to eat a specific type of food, often high-calorie or energy-dense foods. Food noise, by contrast, is constant and generalized. It involves an ongoing preoccupation with food, including repeated thoughts about what to eat, portion sizes, nutritional content, and meal timing.

These thoughts are often accompanied by self-questions such as, "Did I eat enough?" or "Was that too many calories?" Food noise can be sparked by external triggers such as dieting, the presence of food, or food advertisements, or internal ones such as physical hunger. However, food noise frequently occurs even without these cues, making it especially disruptive to daily life and weight management efforts.

In the context of metabolic health, addressing food noise is crucial because it undermines sustained lifestyle changes. For individuals with overweight or obesity, this mental burden can perpetuate cycles of yo-yo dieting and emotional distress, highlighting the need for therapies that target both physiological and psychological aspects of eating behavior.

How GLP-1 RAs Work to Quiet Food Noise

GLP-1 RAs mimic the action of the glucagon-like peptide-1 hormone, which is naturally released in the gut after eating. This hormone regulates blood sugar, slows gastric emptying, and signals fullness to the brain. Beyond these metabolic effects, GLP-1 RAs influence brain regions involved in reward and appetite regulation, potentially reducing the intrusive thoughts associated with food noise.

Certain GLP-1 therapies are proven to significantly reduce food noise.^2,3 By modulating neural pathways linked to food preoccupation, these medications help patients achieve greater mental clarity around eating, fostering long-term adherence to healthier habits.

Key Findings from the INFORM Survey

The US-based INFORM survey provides compelling real-world evidence on GLP-1 RAs' impact on food noise. In this study of 550 individuals using GLP-1s for weight management, participants reported a 46% reduction in constant thoughts about food.² In addition, 64% reported improvements in mental health, and 80% adopted healthier habits.²

"In the US-based INFORM survey, 550 individuals using GLP-1s for weight management reported a 46% reduction in constant thoughts about food. In addition to this, 64% reported improvements in mental health, and 80% adopted healthier habits," informs Dr. Shashank R. Joshi, Consultant Endocrinologist at Lilavati Hospital, Sir HN RFH & Joshi Clinic, Mumbai.

Dr. Joshi's insights underscore the survey's relevance, emphasizing how these outcomes extend GLP-1 RAs' benefits beyond the scale to overall well-being.

Broader Implications for Obesity Care

Food noise is therefore increasingly recognized as a meaningful and important target in obesity care. While further research is needed, these findings point to a possible broader role for GLP-1 RAs beyond weight loss. By influencing behavior, cravings, and mental well-being, they may help people with obesity regain balance, clarity, and healthier everyday lives.

Supporting studies, such as those presented at EASD 2025, reinforce this emerging evidence.^1,4 For instance, research by Arnaut T et al. and Wharton S et al. highlights GLP-1 RAs' potential in reshaping appetite dynamics.^1,4 Additional publications, including Friedrichsen et al. (Diabetes Obes Metab 2021;23:754-62) and Wharton S et al. (Obesity (Silver Spring) 2023;31:703-715), provide foundational data on appetite regulation.^2,3

Clinical Context and Comparisons

Compared to traditional weight loss interventions like diet and exercise alone, GLP-1 RAs offer a pharmacological edge by directly addressing neurological drivers of overeating. Unlike stimulants or appetite suppressants that may cause jitteriness or dependency, GLP-1 RAs promote gradual, sustainable changes. However, they are most effective when combined with lifestyle support, as weight management outcomes may vary depending on individual treatment journeys.

Safety Considerations and Side Effects

GLP-1 RAs are generally well-tolerated for people living with overweight and obesity, but common side effects include nausea, vomiting, and gastrointestinal discomfort, particularly during initiation. Rare but serious risks, such as pancreatitis or thyroid tumors, necessitate medical supervision. Patients should discuss their full medical history with a healthcare provider to ensure suitability.

Monitoring tools can enhance safety; for example, apps like Shotlee allow users to track symptoms, side effects, and medication schedules, helping optimize therapy under professional guidance.

Practical Guidance for Patients

If you're experiencing persistent food noise alongside weight challenges, speak to your doctor to learn more about how GLP-1 RAs could support your weight and health journey. Key discussion points include:

• Your symptoms of food preoccupation and its impact on daily life.
• Current weight, BMI, and metabolic health markers.
• Potential drug interactions or contraindications.
• Strategies for integrating GLP-1 therapy with diet, exercise, and behavioral support.

For people living with overweight and obesity, pursuing GLP-1 RAs should always occur under the guidance of a registered healthcare professional. Individual results vary, and this information is for educational purposes only.

Key Takeaways

• GLP-1 RAs significantly reduce food noise, with a 46% drop in constant food thoughts per the INFORM survey of 550 users.
• 64% of users saw mental health improvements; 80% adopted healthier habits.
• Food noise differs from cravings—it's a constant, distressing preoccupation targetable by GLP-1 therapies.
• Consult a doctor for personalized obesity care; combine with lifestyle changes for best outcomes.

Conclusion: A New Frontier in Metabolic Health

Emerging evidence positions GLP-1 RAs as a promising tool against food noise, potentially transforming obesity treatment from mere weight reduction to comprehensive behavioral and mental health support. Backed by surveys like INFORM and expert input from Dr. Shashank R. Joshi, these findings encourage proactive conversations with healthcare providers. Apis Bull logo and wegowithyou are trademarks of Novo Nordisk A/S.

References:
1. Arnaut T et al. Oral presentation at EASD 2025, Vienna, Austria, 15-19 September 2025
2. Friedrichsen et al. Diabetes Obes Metab 2021;23:754-62
3. Wharton S et al. Obesity (Silver Spring) 2023;31:703-715
4. Wharton S et al. Oral presentation at EASD 2025, Vienna, Austria, 15-19 September 2025
5. Diktas HE et al. Obesity (Silver Spring) 2025;33:289-297
6. Weingarten HP, Elston D. The phenomenology of food cravings. Appetite. 1990;15:231-246. doi: 10.1016/0195-6663(90)90023-2.
7. Diktas HE et al. Obesity (Silver Spring) 2025;33:289-297

Disclaimer: The views/suggestions/opinions expressed are the sole responsibility of the experts and the brand concerned. This should not be considered a substitute for medical advice. Please consult your treating physician. Reviewed on 9/2/2026. Produced on behalf of Novo Nordisk.